Evaluation and Management of Ferritin 277 ng/mL in a 51-Year-Old Woman
A ferritin of 277 ng/mL in a 51-year-old woman requires evaluation for the underlying cause, with the primary focus on distinguishing between iron overload (particularly hemochromatosis), inflammatory conditions causing elevated ferritin, or dysmetabolic iron overload syndrome.
Initial Diagnostic Approach
The critical first step is to measure transferrin saturation (TSAT) to determine if this represents true iron overload or elevated ferritin from another cause 1, 2.
Interpretation Based on TSAT:
If TSAT >45%: This suggests possible hemochromatosis in a woman. According to EASL 2022 guidelines, provisional iron overload in females is defined as TSAT >45% AND ferritin >200 μg/L 2. Your patient meets both criteria.
- Next step: Order HFE genetic testing (C282Y and H63D mutations)
- If homozygous C282Y: Diagnosis of type 1 hemochromatosis is confirmed without need for liver biopsy 3, 2
- If other HFE genotypes or negative: Hepatic iron overload must be confirmed by MRI or liver biopsy 2
- Assess for advanced fibrosis: If ferritin >1000 μg/L, perform liver elastography to identify advanced fibrosis 4. At ferritin 277, this is not immediately necessary unless other risk factors present
- Screen for end-organ damage: Check glucose/HbA1c (diabetes), liver enzymes, assess for arthropathy 2
If TSAT <45% (and particularly <20%): This ferritin level is likely NOT from primary iron overload. Consider:
- Inflammatory conditions: Ferritin is an acute-phase reactant. Check CRP, ESR to identify inflammation 5
- Dysmetabolic iron overload syndrome: Most common iron overload condition, associated with metabolic syndrome (measure waist circumference, check lipids, glucose, blood pressure) 4. This typically shows mild hepatic iron on MRI and phlebotomy is often poorly tolerated without clear benefit 4
- Alcohol intake: Excessive alcohol elevates ferritin without true iron overload 4
- Hepatocellular injury: Check ALT, AST for cytolysis 4
Management Decisions
If Hemochromatosis Confirmed:
Phlebotomy is the definitive treatment with specific targets 3:
- Induction phase target: Ferritin <50 μg/L
- Maintenance phase target: Ferritin 50-100 μg/L (though expert opinion suggests <200 μg/L for women may be acceptable in maintenance phase) 3
- Frequency: 400-500 mL weekly or every 2 weeks during induction, then every 1-4 months during maintenance 3
- Monitor hemoglobin at each session; decrease frequency if Hgb <12 g/dL, stop if <11 g/dL 3
- Monitor ferritin monthly during induction (or every 4th phlebotomy); when <200 μg/L, check every 1-2 sessions 3
- During maintenance: Check ferritin every 6 months 3
Dietary modifications (though these do NOT substitute for phlebotomy) 3:
- Avoid iron supplementation and iron-fortified foods
- Avoid supplemental vitamin C (enhances iron absorption)
- Limit red meat consumption
- Restrict alcohol intake during iron depletion phase
- Critical warning: Avoid raw/undercooked shellfish and seawater wound exposure due to risk of Vibrio vulnificus infection in iron overload 3
If NOT Hemochromatosis:
- Dysmetabolic iron overload: Address metabolic syndrome components; phlebotomy generally not recommended as poorly tolerated without benefit 4
- Inflammatory conditions: Treat underlying inflammation; this ferritin level does not indicate iron deficiency requiring supplementation 5
- No intervention needed if ferritin elevation explained by inflammation, alcohol, or mild metabolic factors
Common Pitfalls to Avoid
- Do not assume iron overload without checking TSAT - ferritin alone is insufficient 1, 2
- Do not start phlebotomy without confirming true iron overload - particularly important in dysmetabolic syndrome where it's ineffective 4
- Do not overlook screening for hepatocellular carcinoma if advanced fibrosis is present in confirmed hemochromatosis 2
- Monitor for over-treatment - ferritin <20 μg/L can cause symptomatic iron deficiency even in hemochromatosis patients 3